Lab X Editorial · Research Procurement
Why "research-grade" doesn't mean what you think
A working note for any lab still ordering peptides on price alone. The label rarely tells you what’s in the vial, and the cost of finding out the hard way is the entire study.
See the full Lab X catalog
LX
Lab X Editorial · published April 2026
7 min read
Updated for 2026 sourcing standards
Open most peptide supplier websites and you’ll see the same sentence: ≥98% pure, research-grade material. It’s the industry’s most-repeated line. It’s also one of the most under-defined. There’s no single regulator that polices what “research-grade” means in this category, and the gap between what suppliers print on a label and what actually arrives in the vial is the silent reproducibility problem in benchtop peptide research.
This piece is opinionated. We sell research peptides for a living, so take that for what it’s worth. But the standards we describe below aren’t ours, they’re drawn from the published quality guidance for synthetic peptide therapeutics[1] and from the analytical conventions every serious supplier already follows when they’re being honest. Most don’t talk about it because it costs money to do, and easier to assert than to prove.
HPLC purity tells you how much of the powder is the molecule you ordered. It does not tell you the molecule is actually what the label says. Those are two separate questions, and you need the answer to both.
◆
What "98% purity" actually measures
Reversed-phase HPLC with UV detection at 214 nm, the wavelength where peptide bonds absorb most strongly[2], separates the components of a peptide sample and quantifies them as a percentage of total area. A reading of 98% means 98% of what your detector sees is the target peptide. The remaining 2% is something else: typically truncation sequences (chains missing one or more residues), deletion sequences, oxidized variants, residual reagents, or trifluoroacetic acid (TFA) salts left over from the cleavage step in solid-phase peptide synthesis[3].
None of those impurities are necessarily catastrophic. Some are. TFA salts in particular have been documented to interfere with cell-based assays and can shift dose-response curves in ways researchers attribute to the target compound when the target compound is innocent[3]. Truncated sequences can compete for the same binding sites. The point isn’t that 98% is too low, for most cell-based assays it’s the accepted research-grade floor[1], the point is that the 2% you don’t see is where the noise in your data comes from.
Identity is a separate question
HPLC tells you purity. It does not tell you identity. A vial can be 99% pure and still be the wrong molecule. That’s why a complete certificate of analysis pairs HPLC purity with mass spectrometry confirming the molecular weight and sequence[1]. If a supplier ships a COA with one and not the other, treat it as half a document.
The HPLC question
How much of the powder is the molecule I ordered? Standard answer: ≥98% by reversed-phase HPLC at 214 nm.
The MS question
Is the molecule actually what the label says? Standard answer: ESI mass spectrometry confirming the expected molecular weight per batch.
“The HPLC chromatograms are batch-specific and matched our independent verification on the first three orders. That’s the standard I needed before committing to a supplier.”
R. Patel
★★★★★
From the bench
Storage is where the spec quietly evaporates
Lyophilization removes water from a peptide sample to under 1% residual moisture, which is the single most important factor in peptide stability, virtually every significant peptide degradation pathway requires water as a reactant or medium[4].
Stored intact at −20°C, lyophilized peptides typically maintain stability for 12-24+ months[4]. The risk isn’t the freezer, it’s everything between the supplier’s freezer and yours. A vial with a compromised seal exposed to ambient humidity for 24 hours can degrade more than a sealed vial that briefly hits 45°C in transit. Moisture ingress is the bigger threat, and it doesn’t show up on the COA.
Looking for documented research peptides?
◆
Where Lab X actually fits in
Lab X Peptides was built around one decision: documentation isn’t a feature, it’s the product. We work with independent testing laboratories on every batch we sell, and we ship lyophilized in vacuum-sealed vials with batch-specific COAs (HPLC + MS) available to qualifying institutions. We don’t compete on price, there are cheaper suppliers, and we don’t make claims about what the compounds do in the body, because that’s not what research-use material is for.
What we sell is consistency. The same molecule, batch over batch, with the same documentation chain. For labs running longitudinal studies or planning to publish, that consistency is the only thing that lets you draw a clean line between your methodology and your results.
“Lab X is the only supplier whose paperwork arrives before the box does. After three years of ordering, I don’t think we’ve ever had to chase a COA.”
Dr. M. Chen
★★★★★
The Lab X Standard
What we ship, and what we'll show you before you order.
01
≥98% HPLC purity
Reversed-phase HPLC at 214 nm, batch by batch.
02
Mass spec identity
ESI-MS confirming molecular weight per batch, paired with the HPLC report.
03
Independent testing
Third-party labs, not in-house only. COAs available to qualifying institutions.
04
Cold-chain ready
Lyophilized, vacuum-sealed, packaged to maintain stability through transit across Canada.
A few of the compounds in our catalog
Every product is supplied lyophilized, in clearly labelled vials, verified for purity and identity prior to distribution.
BPC-157
CJC-1295
Ipamorelin
GHK-Cu
See the full Lab X catalog
◆
The honest test
If you’ve never done it, run a side-by-side. Order the same compound from your current supplier and from one alternative. Send both to the same independent lab for HPLC and MS. Compare the certificates against the actual results. The difference is the difference, and it’s usually large.
Sourcing peptides isn’t sexy work. It’s procurement. But it’s also the variable most labs underweight in their methodology, and the one that, when it goes wrong, looks exactly like a noisy assay until you spot it.
References
- D’Hondt, M. et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharmaceutical Research / USP. pmc.ncbi.nlm.nih.gov/articles/ PMC10338602
- Bachem Knowledge Center. Solid-Phase Peptide Synthesis (SPPS) Explained. bachem.com
- Gyros Protein Technologies. Peptide Purity & Yield Optimizing in SPPS. gyrosproteintechnologies.com
- Sigma-Aldrich. Handling and Storage Guidelines for Peptides and Proteins. sigmaaldrich.com
See what we ship.
Browse the Lab X catalog, every compound is third-party tested with batch-specific documentation.